Effectiveness of Nirsevimab and RSVpreF on Respiratory Syncytial Virus Infections Among Infants in Hawaiʻi, 2023-2025: A Prospective Cohort Study.

Kayla G. Lum, Hawaii Pacific Health, Honolulu, HI, United States; Chieko Kimata, Hawaii Pacific Health, Honolulu, HI, United States; Kara Wong Ramsey, University of Hawaii, John A. Burns School of Medicine, honolulu, HI, United States; Rodolfo Bégué, University of Hawaii, John A. Burns School of Medicine, Honolulu, HI, United States